Serum thyroglobulin level after radioiodine therapy (Day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-11-18

AUTHORS

Yong-il Kim, Hyung-Jun Im, Jin Chul Paeng, Gi Jeong Cheon, Keon Wook Kang, Dong Soo Lee, Do Joon Park, Young Joo Park, June-Key Chung

ABSTRACT

ObjectiveThe utility of serum thyroglobulin (Tg) level, 3 days after radioactive iodine (RAI) therapy, was assessed as a means of predicting successful ablation of thyroid remnant in patients with postoperative thyroid cancer.MethodsA total of 152 patients with thyroid cancer (mean age = 44.9 ± 13.7 year) undergoing RAI therapy after total thyroidectomy were included. Levels of TSH-stimulated Tg prior to ablation (stimTg) and serum Tg sampled immediately after RAI therapy (Day 3) were measured (immTg). ImmTg samples were collected during patient hospital visits for scheduled follow-up of radioiodine scans. Successful ablation was determined by the second time stimulated Tg levels (≤1 ng/ml) and negative radioiodine uptake at thyroid bed after 6.1 ± 1.1 months of RAI therapy. Univariate and multivariate analyses were done for immTg, stimTg, change in Tg levels (deltaTg: immTg − stimTg), immTg:stimTg ratio (ratioTg), and other potential clinical and pathologic markers of successful ablation.ResultsOf selected laboratory variables, ratioTg was a significant predictor of successful ablation. StimTg, tumor diameter, metastatic lymph node (LN) numbers, lymphatic invasion were possible clinical markers of successful ablation by univariate analysis. By multivariate analysis, ratioTg (odds ratio = 7.851), stimTg (odds ratio = 16.819), metastatic LN numbers (odds ratio with stimTg = 6.732) proved significant results. Furthermore, combining high ratioTg and low stimTg provided added predictive value.ConclusionsHigh ratioTg (reflecting extensive release of Tg to the blood after RAI therapy) and low stimTg (reflecting small remnant thyroid tissue) constitute the indices of successful ablation after RAI therapy. Immediate Tg level could give an useful information on RAI ablation of postoperative thyroid remnant. More... »

PAGES

184-189

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12149-014-0927-5

DOI

http://dx.doi.org/10.1007/s12149-014-0927-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043280614

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25404419


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ablation Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iodine Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Period", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroglobulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroid Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroidectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyrotropin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Yong-il", 
        "id": "sg:person.01001337521.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001337521.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Im", 
        "givenName": "Hyung-Jun", 
        "id": "sg:person.01310744444.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310744444.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paeng", 
        "givenName": "Jin Chul", 
        "id": "sg:person.01343511335.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343511335.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheon", 
        "givenName": "Gi Jeong", 
        "id": "sg:person.01333472502.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333472502.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Keon Wook", 
        "id": "sg:person.0761746266.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "id": "sg:person.015617314175.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joon Park", 
        "givenName": "Do", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "Young Joo", 
        "id": "sg:person.012262163264.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012262163264.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "June-Key", 
        "id": "sg:person.0751347234.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13139-011-0107-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011582020", 
          "https://doi.org/10.1007/s13139-011-0107-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-008-0912-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026118139", 
          "https://doi.org/10.1007/s00259-008-0912-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-005-1866-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004216563", 
          "https://doi.org/10.1007/s00259-005-1866-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-008-0997-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015761154", 
          "https://doi.org/10.1007/s00259-008-0997-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-11-18", 
    "datePublishedReg": "2014-11-18", 
    "description": "ObjectiveThe utility of serum thyroglobulin (Tg) level, 3\u00a0days after radioactive iodine (RAI) therapy, was assessed as a means of predicting successful ablation of thyroid remnant in patients with postoperative thyroid cancer.MethodsA total of 152 patients with thyroid cancer (mean age\u00a0=\u00a044.9\u00a0\u00b1\u00a013.7\u00a0year) undergoing RAI therapy after total thyroidectomy were included. Levels of TSH-stimulated Tg prior to ablation (stimTg) and serum Tg sampled immediately after RAI therapy (Day 3) were measured (immTg). ImmTg samples were collected during patient hospital visits for scheduled follow-up of radioiodine scans. Successful ablation was determined by the second time stimulated Tg levels (\u22641\u00a0ng/ml) and negative radioiodine uptake at thyroid bed after 6.1\u00a0\u00b1\u00a01.1\u00a0months of RAI therapy. Univariate and multivariate analyses were done for immTg, stimTg, change in Tg levels (deltaTg: immTg\u00a0\u2212\u00a0stimTg), immTg:stimTg ratio (ratioTg), and other potential clinical and pathologic markers of successful ablation.ResultsOf selected laboratory variables, ratioTg was a significant predictor of successful ablation. StimTg, tumor diameter, metastatic lymph node (LN) numbers, lymphatic invasion were possible clinical markers of successful ablation by univariate analysis. By multivariate analysis, ratioTg (odds ratio\u00a0=\u00a07.851), stimTg (odds ratio\u00a0=\u00a016.819), metastatic LN numbers (odds ratio with stimTg\u00a0=\u00a06.732) proved significant results. Furthermore, combining high ratioTg and low stimTg provided added predictive value.ConclusionsHigh ratioTg (reflecting extensive release of Tg to the blood after RAI therapy) and low stimTg (reflecting small remnant thyroid tissue) constitute the indices of successful ablation after RAI therapy. Immediate Tg level could give an useful information on RAI ablation of postoperative thyroid remnant.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12149-014-0927-5", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1099601", 
        "issn": [
          "0914-7187", 
          "1864-6433"
        ], 
        "name": "Annals of Nuclear Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "keywords": [
      "postoperative thyroid cancer", 
      "serum thyroglobulin levels", 
      "successful ablation", 
      "RAI therapy", 
      "TG levels", 
      "thyroglobulin levels", 
      "thyroid remnants", 
      "thyroid cancer", 
      "multivariate analysis", 
      "metastatic lymph node number", 
      "metastatic LN number", 
      "postoperative thyroid remnants", 
      "radioactive iodine therapy", 
      "lymph node number", 
      "levels of TSH", 
      "possible clinical markers", 
      "patient hospital visits", 
      "RAI ablation", 
      "iodine therapy", 
      "total thyroidectomy", 
      "radioiodine scan", 
      "thyroid bed", 
      "radioiodine therapy", 
      "laboratory variables", 
      "tumor diameter", 
      "radioiodine uptake", 
      "lymphatic invasion", 
      "hospital visits", 
      "pathologic markers", 
      "serum Tg", 
      "univariate analysis", 
      "clinical markers", 
      "LN number", 
      "predictive value", 
      "therapy", 
      "significant predictors", 
      "patients", 
      "cancer", 
      "ablation", 
      "markers", 
      "thyroidectomy", 
      "levels", 
      "ResultsOf", 
      "TSH", 
      "second time", 
      "thyroid", 
      "visits", 
      "months", 
      "significant results", 
      "scans", 
      "total", 
      "predictors", 
      "invasion", 
      "days", 
      "uptake", 
      "index", 
      "remnants", 
      "useful information", 
      "analysis", 
      "number", 
      "Tg", 
      "utility", 
      "changes", 
      "samples", 
      "variables", 
      "ratio", 
      "time", 
      "bed", 
      "diameter", 
      "results", 
      "node number", 
      "information", 
      "means", 
      "values"
    ], 
    "name": "Serum thyroglobulin level after radioiodine therapy (Day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer", 
    "pagination": "184-189", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043280614"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12149-014-0927-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25404419"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12149-014-0927-5", 
      "https://app.dimensions.ai/details/publication/pub.1043280614"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_620.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12149-014-0927-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12149-014-0927-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12149-014-0927-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12149-014-0927-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12149-014-0927-5'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      21 PREDICATES      117 URIs      105 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12149-014-0927-5 schema:about N087c69953fac49b08c543a859286cb12
2 N0eb819389f044cd7b380505f784c0d16
3 N1bcf9936b3ad4ff896dd7b4b51d88db7
4 N1be8cd8eef9b48de9dd89823a3351799
5 N24c7cfdc66634f058565df216abd8552
6 N46738e2294b04a28be3fc5b957fd3435
7 N658e3739e0cd40e18703d124978114fb
8 N7aacf3c6461b4689bd51e90d4be4bf95
9 Na591e728f53e493b81d6d06bf8cf364a
10 Nc6610535e7bb4b84a84f9e711fb2e7e7
11 Ndcb832da815e406e9546212582722414
12 Nf05331e0eef7498cb25b2cac4321451e
13 Nf63049565d4c4968813ee8e8d533ef53
14 Nfd4d8da0b0ba4e858a4ed922dd9a9f39
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N978b94ca80754190bb7189a17cba6aa0
18 schema:citation sg:pub.10.1007/s00259-005-1866-0
19 sg:pub.10.1007/s00259-008-0912-0
20 sg:pub.10.1007/s00259-008-0997-5
21 sg:pub.10.1007/s13139-011-0107-7
22 schema:datePublished 2014-11-18
23 schema:datePublishedReg 2014-11-18
24 schema:description ObjectiveThe utility of serum thyroglobulin (Tg) level, 3 days after radioactive iodine (RAI) therapy, was assessed as a means of predicting successful ablation of thyroid remnant in patients with postoperative thyroid cancer.MethodsA total of 152 patients with thyroid cancer (mean age = 44.9 ± 13.7 year) undergoing RAI therapy after total thyroidectomy were included. Levels of TSH-stimulated Tg prior to ablation (stimTg) and serum Tg sampled immediately after RAI therapy (Day 3) were measured (immTg). ImmTg samples were collected during patient hospital visits for scheduled follow-up of radioiodine scans. Successful ablation was determined by the second time stimulated Tg levels (≤1 ng/ml) and negative radioiodine uptake at thyroid bed after 6.1 ± 1.1 months of RAI therapy. Univariate and multivariate analyses were done for immTg, stimTg, change in Tg levels (deltaTg: immTg − stimTg), immTg:stimTg ratio (ratioTg), and other potential clinical and pathologic markers of successful ablation.ResultsOf selected laboratory variables, ratioTg was a significant predictor of successful ablation. StimTg, tumor diameter, metastatic lymph node (LN) numbers, lymphatic invasion were possible clinical markers of successful ablation by univariate analysis. By multivariate analysis, ratioTg (odds ratio = 7.851), stimTg (odds ratio = 16.819), metastatic LN numbers (odds ratio with stimTg = 6.732) proved significant results. Furthermore, combining high ratioTg and low stimTg provided added predictive value.ConclusionsHigh ratioTg (reflecting extensive release of Tg to the blood after RAI therapy) and low stimTg (reflecting small remnant thyroid tissue) constitute the indices of successful ablation after RAI therapy. Immediate Tg level could give an useful information on RAI ablation of postoperative thyroid remnant.
25 schema:genre article
26 schema:isAccessibleForFree false
27 schema:isPartOf N77a517314b4b46be9158d0012aa2e97c
28 Nbc383cafa0fc4d41add199476d63b897
29 sg:journal.1099601
30 schema:keywords LN number
31 RAI ablation
32 RAI therapy
33 ResultsOf
34 TG levels
35 TSH
36 Tg
37 ablation
38 analysis
39 bed
40 cancer
41 changes
42 clinical markers
43 days
44 diameter
45 hospital visits
46 index
47 information
48 invasion
49 iodine therapy
50 laboratory variables
51 levels
52 levels of TSH
53 lymph node number
54 lymphatic invasion
55 markers
56 means
57 metastatic LN number
58 metastatic lymph node number
59 months
60 multivariate analysis
61 node number
62 number
63 pathologic markers
64 patient hospital visits
65 patients
66 possible clinical markers
67 postoperative thyroid cancer
68 postoperative thyroid remnants
69 predictive value
70 predictors
71 radioactive iodine therapy
72 radioiodine scan
73 radioiodine therapy
74 radioiodine uptake
75 ratio
76 remnants
77 results
78 samples
79 scans
80 second time
81 serum Tg
82 serum thyroglobulin levels
83 significant predictors
84 significant results
85 successful ablation
86 therapy
87 thyroglobulin levels
88 thyroid
89 thyroid bed
90 thyroid cancer
91 thyroid remnants
92 thyroidectomy
93 time
94 total
95 total thyroidectomy
96 tumor diameter
97 univariate analysis
98 uptake
99 useful information
100 utility
101 values
102 variables
103 visits
104 schema:name Serum thyroglobulin level after radioiodine therapy (Day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer
105 schema:pagination 184-189
106 schema:productId Na184fbffdc0d4a99932a97eb33ea1f44
107 Nadeca89e08e44b44afb8399541ce9d22
108 Nd3bdf759a2924d208f214523823c7095
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043280614
110 https://doi.org/10.1007/s12149-014-0927-5
111 schema:sdDatePublished 2022-10-01T06:39
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher N191a4b7342c84c52af0fd4a7aa64cbae
114 schema:url https://doi.org/10.1007/s12149-014-0927-5
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N087c69953fac49b08c543a859286cb12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Thyroid Neoplasms
120 rdf:type schema:DefinedTerm
121 N0eb819389f044cd7b380505f784c0d16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Thyroidectomy
123 rdf:type schema:DefinedTerm
124 N138b79474df34f659363238ac25d047b rdf:first sg:person.01343511335.32
125 rdf:rest Nca51a6ce8b7441a6bbd9e70783bd0954
126 N191a4b7342c84c52af0fd4a7aa64cbae schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 N1bcf9936b3ad4ff896dd7b4b51d88db7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Iodine Radioisotopes
130 rdf:type schema:DefinedTerm
131 N1be8cd8eef9b48de9dd89823a3351799 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Middle Aged
133 rdf:type schema:DefinedTerm
134 N24c7cfdc66634f058565df216abd8552 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Thyroglobulin
136 rdf:type schema:DefinedTerm
137 N3c40c56c90184d0c86a8c847064c7cea rdf:first sg:person.0751347234.39
138 rdf:rest rdf:nil
139 N46738e2294b04a28be3fc5b957fd3435 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Prognosis
141 rdf:type schema:DefinedTerm
142 N658e3739e0cd40e18703d124978114fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Male
144 rdf:type schema:DefinedTerm
145 N6857623ca66c4f599dcd2831a8d81730 schema:affiliation grid-institutes:grid.31501.36
146 schema:familyName Joon Park
147 schema:givenName Do
148 rdf:type schema:Person
149 N77a517314b4b46be9158d0012aa2e97c schema:volumeNumber 29
150 rdf:type schema:PublicationVolume
151 N7aacf3c6461b4689bd51e90d4be4bf95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Multivariate Analysis
153 rdf:type schema:DefinedTerm
154 N827db00cdfd941d384ff7da59ce5c222 rdf:first sg:person.0761746266.86
155 rdf:rest Ne40749387a974723bbb8d53be96f02ce
156 N845c39d6436c4e0c8f2d4f9884d31645 rdf:first sg:person.01310744444.16
157 rdf:rest N138b79474df34f659363238ac25d047b
158 N978b94ca80754190bb7189a17cba6aa0 rdf:first sg:person.01001337521.67
159 rdf:rest N845c39d6436c4e0c8f2d4f9884d31645
160 Na184fbffdc0d4a99932a97eb33ea1f44 schema:name doi
161 schema:value 10.1007/s12149-014-0927-5
162 rdf:type schema:PropertyValue
163 Na591e728f53e493b81d6d06bf8cf364a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Ablation Techniques
165 rdf:type schema:DefinedTerm
166 Nadeca89e08e44b44afb8399541ce9d22 schema:name dimensions_id
167 schema:value pub.1043280614
168 rdf:type schema:PropertyValue
169 Nbc383cafa0fc4d41add199476d63b897 schema:issueNumber 2
170 rdf:type schema:PublicationIssue
171 Nc6610535e7bb4b84a84f9e711fb2e7e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Treatment Outcome
173 rdf:type schema:DefinedTerm
174 Nc812727094c24798929755f97562a899 rdf:first N6857623ca66c4f599dcd2831a8d81730
175 rdf:rest Ndb169fe80bbd4279a5356964b0af0bcf
176 Nca51a6ce8b7441a6bbd9e70783bd0954 rdf:first sg:person.01333472502.31
177 rdf:rest N827db00cdfd941d384ff7da59ce5c222
178 Nd3bdf759a2924d208f214523823c7095 schema:name pubmed_id
179 schema:value 25404419
180 rdf:type schema:PropertyValue
181 Ndb169fe80bbd4279a5356964b0af0bcf rdf:first sg:person.012262163264.27
182 rdf:rest N3c40c56c90184d0c86a8c847064c7cea
183 Ndcb832da815e406e9546212582722414 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Female
185 rdf:type schema:DefinedTerm
186 Ne40749387a974723bbb8d53be96f02ce rdf:first sg:person.015617314175.88
187 rdf:rest Nc812727094c24798929755f97562a899
188 Nf05331e0eef7498cb25b2cac4321451e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Postoperative Period
190 rdf:type schema:DefinedTerm
191 Nf63049565d4c4968813ee8e8d533ef53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Thyrotropin
193 rdf:type schema:DefinedTerm
194 Nfd4d8da0b0ba4e858a4ed922dd9a9f39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Humans
196 rdf:type schema:DefinedTerm
197 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
198 schema:name Medical and Health Sciences
199 rdf:type schema:DefinedTerm
200 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
201 schema:name Oncology and Carcinogenesis
202 rdf:type schema:DefinedTerm
203 sg:journal.1099601 schema:issn 0914-7187
204 1864-6433
205 schema:name Annals of Nuclear Medicine
206 schema:publisher Springer Nature
207 rdf:type schema:Periodical
208 sg:person.01001337521.67 schema:affiliation grid-institutes:grid.31501.36
209 schema:familyName Kim
210 schema:givenName Yong-il
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001337521.67
212 rdf:type schema:Person
213 sg:person.012262163264.27 schema:affiliation grid-institutes:grid.31501.36
214 schema:familyName Park
215 schema:givenName Young Joo
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012262163264.27
217 rdf:type schema:Person
218 sg:person.01310744444.16 schema:affiliation grid-institutes:grid.31501.36
219 schema:familyName Im
220 schema:givenName Hyung-Jun
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310744444.16
222 rdf:type schema:Person
223 sg:person.01333472502.31 schema:affiliation grid-institutes:grid.31501.36
224 schema:familyName Cheon
225 schema:givenName Gi Jeong
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333472502.31
227 rdf:type schema:Person
228 sg:person.01343511335.32 schema:affiliation grid-institutes:grid.31501.36
229 schema:familyName Paeng
230 schema:givenName Jin Chul
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343511335.32
232 rdf:type schema:Person
233 sg:person.015617314175.88 schema:affiliation grid-institutes:grid.31501.36
234 schema:familyName Lee
235 schema:givenName Dong Soo
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88
237 rdf:type schema:Person
238 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.31501.36
239 schema:familyName Chung
240 schema:givenName June-Key
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
242 rdf:type schema:Person
243 sg:person.0761746266.86 schema:affiliation grid-institutes:grid.31501.36
244 schema:familyName Kang
245 schema:givenName Keon Wook
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86
247 rdf:type schema:Person
248 sg:pub.10.1007/s00259-005-1866-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004216563
249 https://doi.org/10.1007/s00259-005-1866-0
250 rdf:type schema:CreativeWork
251 sg:pub.10.1007/s00259-008-0912-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026118139
252 https://doi.org/10.1007/s00259-008-0912-0
253 rdf:type schema:CreativeWork
254 sg:pub.10.1007/s00259-008-0997-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015761154
255 https://doi.org/10.1007/s00259-008-0997-5
256 rdf:type schema:CreativeWork
257 sg:pub.10.1007/s13139-011-0107-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011582020
258 https://doi.org/10.1007/s13139-011-0107-7
259 rdf:type schema:CreativeWork
260 grid-institutes:grid.31501.36 schema:alternateName Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
261 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
262 Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
263 Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea
264 schema:name Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
265 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
266 Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
267 Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...